UBS AG - Listing of the UBS Autocallable Note linked to SPX, SMI, SX5E, and NKY, due 2031 Series 24

Listing of the UBS Autocallable Note linked to SPX, SMI, SX5E, and NKY, due 2031 – Series 24

UBS AG, London Branch
("UBS AG" or the "Company")
(Incorporated and domiciled in Switzerland)
(Registration number: CHE-101.329.561)

Listing of the UBS Autocallable Note linked to SPX, SMI, SX5E, and NKY, due
2031 – Series 24.

The JSE Limited has granted UBS approval for the listing of the Autocallable
Note linked to the SPX, SMI, SX5E, and NKY indices due 20 October 2031.

Trading will commence on Thursday, 20 November 2025.

INSTRUMENT NUMBER:                          124042

ALPHA CODE:                                 UBS006

ISIN:                                       ZAE000354346

ISSUE SIZE (UNITS):                         100,000 (unit quotation)

ISSUE PRICE (RAND/UNIT):                    1,000

LISTING DATE:                               20   November 2025
EXPIRY DATE:                                20   October 2031
EXPIRY OBSERVATION DATE:                    20   October 2031
FINALISATON ANNOUNCEMENT BY 08:00AM:        21   October 2031
LAST DATE TO TRADE:                         21   October 2031
SUSPENSION DATE:                            22   October 2031
RECORD DATE:                                24   October 2031
PAYMENT DATE:                               27   October 2031
TERMINATION DATE:                           28   October 2031

For further information kindly contact:

UBS KeyInvest South Africa
Tel.: +27 11 322 7129 / 7000
E-mail: keyinvestza@ubs.com
Web: http://keyinvest-za.ubs.com/products

Johannesburg
19 November 2025

Sponsor: UBS South Africa (Pty) Limited

Date: 19-11-2025 10:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.